Screening and Management of High-risk Populations of Stroke in Dehui City

Stroke Clinical Trial

— SAMHPSDC  

Official title:

Screening and Management of High-risk Populations of Stroke in Dehui City

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05039034
• Other study ID #: SMDC
• Status: Completed
• Start date: January 1, 2016
• Est. completion date: March 31, 2017

Study information

• Verified date: August 2021
• Source: The First Hospital of Jilin University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4100
• Est. completion date: March 31, 2017
• Est. primary completion date: March 31, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Aged 40 years and over in Dehui City

• Willing to participate in the study and follow-up visits

• Signed an informed consent

Exclusion Criteria:

• Life expectancy<3 years

• Unwilling to participate in the study and follow-up visits

• Living away from Dehui City over 6 months

• Unable to cooperate with examination and questionnaire due to mental disease

Related Conditions & MeSH terms

• Cerebrovascular Accident
• Diabetes Mellitus
• Dyslipidemias
• Hypertension
• Stroke

Intervention

Other:
• Advice according to primary prevention guidelines on stroke of China

Locations

Country	Name	City	State
China	First Hospital of Jilin University	Changchun	Jilin

Sponsors (2)

Lead Sponsor	Collaborator
Yi Yang	Dehui People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence rate of stroke	The proportion of stroke in the general population.	4 months
Primary	Prevalence rate of hypertension	The proportion of hypertension in the general population.	4 months
Primary	Prevalence rate of diabetes mellitus	The proportion of diabetes mellitus in the general population.	4 months
Primary	Prevalence rate of dyslipidemia	The proportion of dyslipidemia in the general population.	4 months